• Journal of Microbiology and Biotechnology
• /
• 제21권5호
• /
• pp.449-454
• /
• 2011

The infection of pandemic influenza viruses such as swine flu (H1N1) and avian flu viruses to the host cells is related to the following two factors: First, the surface protein such as HA (hemagglutinin) and NA (neuraminidase) of the influenza virus. Second, the specific structure of the oligosaccharide [sialic acid(${\alpha}2$-6) galactose(${\beta}1$-4)glucose or sialic acid(${\alpha}2$-3)galactose(${\beta}1$-4)glucose] on the host cell. After recognizing the specific structure of the oligosaccharide on the surface of host cells by the surface protein of the influenza virus, the influenza virus can secrete sialidase and cleave the sialic acid attached on the final position of the specific structure of the oligosaccharide on the surface of host cells. Tamiflu (oseltamivir), known as a remedy of swine flu, has a saccharide analog structure, especially the sialic acid analog. Tamiflu can inhibit the invasion of influenza viruses (swine flu and avian flu viruses) into the host cells by competition with sialic acid on the terminal position of the specific oligosaccharide on the surface of the host cell. Because of the emergence of Tamiflu resistance, the development of new potent anti-influenza inhibitors is needed. The inhibitors with positive-charge groups have potential as antiviral therapeutics, and the strain specificity must also be resolved.

• 약학회지
• /
• 제43권4호
• /
• pp.469-473
• /
• 1999

EA, the water soluble substance, was prepared from the carpophores of Elfvingia applanata (Pers). Karst. Anti-influenza A virus (anti-Flu A) activity of EA was examined of Vero cells by plaque reduction assay in vitro. And the combined antiviral effects fo EA with interferon (IFN) alpha and gamma were examined on the multiplication of Flu A with 50% effective concentration ($EC_50$) of 1.50 mg/ml. The results of combination assay were evaluated by the combination index (CI) that was analysed by the multiple drug effect analysis. The combination of EA with IFN alpha on Flu A showed more potent synergism with CI values of 0.50~0.52 of 50%, 70%, 90% effective levels than that with IFN gamma with CI values of 0.82~0.99.

• 대한임상검사과학회지
• /
• 제42권1호
• /
• pp.1-15
• /
• 2010

Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) is endemic in swine, and classified into influenza A and influenza C but not influenza B. Swine influenza A includes H1N1, H1N2, H3N1, H3N2 and H2N3 subtypes. Infection of SIV occurs in only swine and that of S-OIV is rare in human. What human can be infected with S-OIV is called as zoonotic swine flu. Pandemic 2009 swine influenza H1N1 virus (2009 H1N1) was emerged in Mexico, America and Canada and spread worldwide. The triple-reassortant H1N1 resulting from antigenic drift was contained with HA, NA and PB1 of human or swine influenza virus, PB2 and PA polymerase of avian influenza virus, and M, NP and NS of swine influenza virus, The 2009 H1N1 enables to transmit to human and swine. The symptoms and signs in human infected with 2009 H1N1 virus are fever, cough and sore throat, pneumonia as well as diarrhea and vomiting. Co-infection with other viruses and bacteria such as Streptococcus pneumoniae can occur high mortality in high-risk population. 2009 H1N1 virus was easily differentiated from seasonal flu by real time RT-PCR which contributed rapid and confirmed diagnosis. The 2009 H1N1 virus was treated with NA inhibitors such as oseltamivir (Tamiflu) and zanamivir (Relenza) but not with adamantanes such as amantadine and rimantadine. Evolution of influenza virus has continued in various hosts. Development of a more effective vaccine against influenza prototypes is needed to protect new influenza infection such as H5 and H7 subtypes to infect to multi-organ and cause high pathogenicity.

• 기술사
• /
• 제42권6호
• /
• pp.42-46
• /
• 2009

Every year influenza contributes to the death of 72 people in the South korea, 20,000 in the U.S. and perhaps millions worldwide. The swine fever so-called the noble flu A H1N1, a strain of the flu virus, which jumped species and burst into the human population in March and April of this year. The outbreak of 2009 novel H1N1 was the fourth in 100 years. Fortunately, it led to today's comparatively tame swine flu than the vicious 1918, which was original H1N1 pandemic flu virus, killed at least 40 million worldwide in an ongoing pandemic era. Although the 2009 H1N1 which is still in full swing, this global flu epidemic is already teaching scientists valuable lessons about pandemics. Evidence accumulated these days indicates that the 2009 H1N1 was not entirely new to all human immune systems. This article introduces only an outline for our better understanding the basic mechanisms of influenza and the vaccination about longstanding fears of that worst-case scenario engendered pandemic that are paying off today.

• Journal of Microbiology and Biotechnology
• /
• 제20권1호
• /
• pp.63-70
• /
• 2010

Novel influenza A (H1N1) is a newly emerged flu virus that was first detected in April 2009. Unlike the avian influenza (H5N1), this virus has been known to be able to spread from human to human directly. Although it is uncertain how severe this novel H1N1 virus will be in terms of human illness, the illness may be more widespread because most people will not have immunity to it. In this study, we compared the codon usage bias between the novel H1N1 influenza A viruses and other viruses such as H1N1 and H5N1 subtypes to investigate the genomic patterns of novel influenza A (H1N1). Totally, 1,675 nucleotide sequences of the hemagglutinin (HA) and neuraminidase (NA) genes of influenza A virus, including H1N1 and H5N1 subtypes occurring from 2004 to 2009, were used. As a result, we found that the novel H1N1 influenza A viruses showed the most close correlations with the swine-origin H1N1 subtypes than other H1N1 viruses, in the result from not only the analysis of nucleotide compositions, but also the phylogenetic analysis. Although the genetic sequences of novel H1N1 subtypes were not exactly the same as the other H1N1 subtypes, the HA and NA genes of novel H1N1s showed very similar codon usage patterns with other H1N1 subtypes, especially with the swine-origin H1N1 influenza A viruses. Our findings strongly suggested that those novel H1N1 viruses seemed to be originated from the swine-host H1N1 viruses in terms of the codon usage patterns.

• Journal of Microbiology and Biotechnology
• /
• 제22권8호
• /
• pp.1165-1169
• /
• 2012

In April 2009, the H1N1 pandemic influenza virus emerged as a novel influenza virus. The aim of this study was to compare the performances of several molecular assays, including conventional reverse transcription polymerase chain reaction (RT-PCR), two real-time reverse transcription (rRT)-PCRs, and two multiplex RTPCRs. A total of 381 clinical specimens were collected from patients (223 men and 158 women), and both the Seeplex RV7 assay and rRT-PCR were ordered on different specimens within one week after collection. The concordance rate for the two methods was 87% (332/381), and the discrepancy rate was 13% (49/381). The positive rates for the molecular assays studied included 93.1% for the multiplex Seeplex RV7 assay, 93.1% for conventional reverse transcription (cRT)-PCR, 89.7% for the multiplex Seeplex Flu ACE Subtyping assay, 82.8% for protocol B rRT-PCR, and 58.6% for protocol A rRT-PCR. Our results showed that the multiplex Seeplex assays and the cRT-PCR yielded higher detection rates than rRT-PCRs for detecting the influenza A (H1N1) virus. Although the multiplex Seeplex assays had the advantage of simultaneous detection of several viruses, they were time-consuming and troublesome. Our results show that, although rRT-PCR had the advantage, the detection rates of the molecular assays varied depending upon the source of the influenza A (H1N1)v virus. Our findings also suggest that rRT-PCR sometimes detected virus in extremely low abundance and thus required validation of analytical performance and clinical correlation.

• 한국식품영양과학회지
• /
• 제29권1호
• /
• pp.128-133
• /
• 2000

This study was designed to verify the efficacy of garlic extracts for protecting the infecton of influenza and Japanese B encephalitis virus. Influenza virus (AO/PR8 strain) and Japanese B encephalitis virus (JaGAr O1 strain) were used to attack mouse through nasal route and each vaccines were injected subcutaneously. 0.002 and 0.2 mL/day of garlic extracts were orally administered to mice. The blood and serum samples were taken from the mice to measure LD50, Defense Index (DI), virus-neutralizing antibody for comparing virus influence inhibiting activities. Defense indices of the male and female mice were not significantly different at every experiment. Vaccination effectively inhibited the influence of influenza virus and 0.002 mL/day garlic extract (0.55$\pm$0.05) resulted in significantly higher DI than the control (0$\pm$0.05) (p<0.05). Although 0.002 mL/day garlic extract (0.55$\pm$0.05) resulted in significantly lower DI than the vaccination (1.10$\pm$0.05), 0.2 mL/day garlic extract (2.05$\pm$0.05) resulted in 10 times higher DI than the vaccination (1.10$\pm$0.05). Garlic extract did not affect DI in Japanese B encephalitis virus influence of the vaccinated mouse, but significantly reduced DI of the non-vaccinated mouse (p<0.05). Garlic extracts did not affect the production of the neutralizing antibody against influenza by vaccination. However, neutralizing antibody production of Japanese B encephalitis was accelerated by vaccination. Consequently, the current study proved the efficacy of garlic on inhibition of influenza virus. Finally, it is very hard to show the higher preventing effect on flu through ingestion of garlic as a food than vaccination.

• Clinical and Experimental Pediatrics
• /
• 제48권3호
• /
• pp.266-275
• /
• 2005

목 적 : 바이러스는 소아 하기도 감염증의 가장 흔한 원인으로 소아에서 흔히 이환되어 모세기관지염, 폐렴, 크룹, 기관 기관지염 등의 하기도 감염을 일으키는 원인 바이러스들로서 이들의 유행 시기 및 임상 양상을 조사하여 각 질환의 특성을 알아 보고자 하였다. 방 법 : 1998년 9월부터 2003년 5월까지 한림대학교 한강성심병원과 강남성심병원 소아과에 급성 호흡기 감염증으로 입원했던 환아 10,630명 중 총 4,554례에서 비인두 흡인물을 채취하여 바이러스 배양 및 단일 클론 항체를 이용한 면역 형광 검사법으로 881례(19%)에서 호흡기바이러스가 분리되었다. 그 중 모세기관지염, 폐렴, 크룹, 기관 기관지염 등의 급성 하기도 감염증으로 진단 받은 837례의 의무기록을 후향적으로 고찰하였다. 결 과 : 1) RSV가 485례(55%)로 가장 많았고, PIV 152례(17%), FluA 114례(13%), ADV 79례(9%), FluB 51례(6%) 순이었다. 2) 발생시기는 RSV의 경우 연중 발생하였고, 주로 11-12월에 많았다. PIV 매년 4-6월에 최고치를 이루었고, FluA는 매년 11-12월부터 다음해 1월까지 발생하였으나, 2002년 1월과 11월에 가장 많았다. FluB는 매년 3-4월에 유행하였고, 그 중 2002년 4월에 최고치를 이루었다. ADV는 연중 비슷하게 발생하였다. 3) 남녀 성별 비는 3 : 2로 남아가 더 많았고, 중앙연령은 9개월이었다. 4) 임상적 진단에는 세기관지염 395례(47%), 폐렴 305례(36%), 크룹73례(9%), 기관 기관지염 64례(8%)의 순이었고, RSV의 경우 세기관지염이 280례(60%)였다. 5) 임상증상 및 징후에는 각 바이러스 모두 기침(96%), 가래(83%), 비루(65%), 발열(61%)이 많았고, ADV는 설사(23%)가 다른 바이러스에 비해 많았다. 6) 청진 소견으로 천명음이 들렸던 경우는 RSV가 55%로 많았고, 수포음은RSV(47%), ADV(43%), FluA(40%) 순이었다. 건성수포음은 FluB가 49%로 많았으며, 협착음은 PIV가 27%로 높았다. 7) 말초 혈액 백혈구 수는 전체 62%에서 정상이었고, 36%에서 증가하였다. 적혈구 침강 속도는 30%에서 증가하였고, C 반응 단백은 20%에서 양성이었다. 8) 방사선 소견은 고찰이 가능하였던 803례 중 각 바이러스 모두 정상 소견이 557례(69%)로 가장 많았고, 특징적으로 하인두 확장은 PIV에서 31례(21%)로 현저하게 많았다. 결 론 : 소아에서 급성 하기도 감염증의 중요한 원인을 차지하는 호흡기 바이러스는 각각 발생시기 및 유행 양상에서 차이를 보였으나, 임상 양상은 서로 비슷하였고, 배양검사 결과가 확인되기 이전에 정확한 원인 바이러스를 예측하고 규명하기에는 어려운 점이 있었다. 이에 질병을 예측할 수 있는 신속한 진단법들이 개발되어 항바이러스제제를 적절한 시기에 선택하고 또한 예방접종시기를 예측하는데 도움이 되어야겠다.

• IMMUNE NETWORK
• /
• 제20권4호
• /
• pp.32.1-32.15
• /
• 2020

Influenza virus is the major cause of seasonal and pandemic flu. Currently, oseltamivir, a potent and selective inhibitor of neuraminidase of influenza A and B viruses, is the drug of choice for treating patients with influenza virus infection. However, recent emergence of oseltamivir-resistant influenza viruses has limited its efficacy. Morin hydrate (3,5,7,2',4'-pentahydroxyflavone) is a flavonoid isolated from Morus alba L. It has antioxidant, anti-inflammatory, neuroprotective, and anticancer effects partly by the inhibition of the NF-κB signaling pathway. However, its effects on influenza virus have not been studied. We evaluated the antiviral activity of morin hydrate against influenza A/Puerto Rico/8/1934 (A/PR/8; H1N1) and oseltamivir-resistant A/PR/8 influenza viruses in vitro. To determine its mode of action, we carried out time course experiments, and time of addition, hemolysis inhibition, and hemagglutination assays. The effects of the co-administration of morin hydrate and oseltamivir were assessed using the murine model of A/PR/8 infection. We found that morin hydrate reduced hemagglutination by A/PR/8 in vitro. It alleviated the symptoms of A/PR/8-infection, and reduced the levels of pro-inflammatory cytokines and chemokines, such as TNF-α and CCL2, in infected mice. Co-administration of morin hydrate and oseltamivir phosphate reduced the virus titers and attenuated pulmonary inflammation. Our results suggest that morin hydrate exhibits antiviral activity by inhibiting the entry of the virus.

• Journal of the Korean Data and Information Science Society
• /
• 제26권5호
• /
• pp.1087-1095
• /
• 2015

인플루엔자는 흔히 독감으로 불리는 질병으로 인플루엔자 바이러스가 호흡기 (코, 인후, 기관지, 폐 등)에 감염되어 생기는 병이다. 감기와는 달리 심한 증상을 나타내거나 생명이 위험한 합병증 (폐렴 등)을 유발할 수도 있다. 본 연구에서는 인플루엔자에 대한 예측모형을 다루었으며, 주로 회귀적인 모형을 고려하였다. 기존의 연구들이 주로 기상요인을 예측변수로 사용한 반면, 본 연구에서는 소셜요인의 효과를 살펴보았으며 그 결과 기상요인과 대등한 설명력을 가짐을 확인하였다. 반응변수로는 국민건강보험공단에서 제공하는 인플루엔자 진료건수가 사용되었고, 설명변수에는 기상청에서 제공하는 기상정보와 트위터에서의 인플루엔자 연관키워드 빈도가 사용되었다. 모형의 비교를 위해 시계열 모형도 함께 제시되었다.